| pubmed-article:3209617 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C0042449 | lld:lifeskim |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C0041637 | lld:lifeskim |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C1579762 | lld:lifeskim |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C0009491 | lld:lifeskim |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C0190932 | lld:lifeskim |
| pubmed-article:3209617 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:3209617 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:3209617 | pubmed:dateCreated | 1989-2-22 | lld:pubmed |
| pubmed-article:3209617 | pubmed:abstractText | This study is based on 223 consecutive femoro-popliteal and femorotibial bypass grafts performed between January 1978 and June 1985 at the Western General Hospital. Autogenous vein grafts demonstrated better 5 year patency rates (54%) than modified human umbilical vein (32%). The superiority of autogenous vein was even more marked when anastomoses were to below knee vessels: 56% compared with 26% at 5 years. Grafts anastomosed to the superficial femoral artery had similar long term patency to those anastomosed to the common femoral artery. When grafts were required for severe ischaemia, similar 5 year patency rates were achieved with autogenous vein (35%) and modified human umbilical vein (30%). The 5 year limb salvage rate in severe ischaemia was 72% for autogenous vein and 63% for modified human umbilical vein. The findings confirm that modified human umbilical vein is a satisfactory alternative when autogenous vein is not available. | lld:pubmed |
| pubmed-article:3209617 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3209617 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3209617 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3209617 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3209617 | pubmed:issn | 0021-9509 | lld:pubmed |
| pubmed-article:3209617 | pubmed:author | pubmed-author:KindR ERE | lld:pubmed |
| pubmed-article:3209617 | pubmed:author | pubmed-author:DevineT JTJ | lld:pubmed |
| pubmed-article:3209617 | pubmed:author | pubmed-author:FellGG | lld:pubmed |
| pubmed-article:3209617 | pubmed:author | pubmed-author:ParkerH JHJ | lld:pubmed |
| pubmed-article:3209617 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3209617 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:3209617 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3209617 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3209617 | pubmed:pagination | 727-32 | lld:pubmed |
| pubmed-article:3209617 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:meshHeading | pubmed-meshheading:3209617-... | lld:pubmed |
| pubmed-article:3209617 | pubmed:articleTitle | Femoropopliteal bypass using autogenous vein and modified human umbilical vein. A comparative study. | lld:pubmed |
| pubmed-article:3209617 | pubmed:affiliation | Western General Hospital Vascular Unit, Melbourne, Australia. | lld:pubmed |
| pubmed-article:3209617 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3209617 | pubmed:publicationType | Comparative Study | lld:pubmed |
